Brind.

Anne Wojcicki uses her nonprofit to acquire 23andMe amidst a lawsuit led by Letitia James regarding genetic data privacy, while TTAM submitted a higher unsolicited offer than Regeneron.

Steady: 0 in the last 7 days Updated oct 13

The latest in this situation

  1. Anne Wojcicki's board includes experts such as Alexis Battle.

How it started

1 report, 0 independent, last reported Jun 21. The briefing below covers this first event.

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Anne Wojcicki uses her nonprofit to acquire 23andMe amidst a lawsuit led by Letitia James regarding genetic data privacy, while TTAM submitted a higher unsolicited offer than Regeneron.

Who's involved

What this event is mainly about
Anne WojcickiLetitia JamesTTAM Research InstituteRegeneron Pharmaceuticals

How it developed

Newest first. Tap a step to see who reported it.
  1. Anne Wojcicki's board includes experts such as Alexis Battle.Sub-event
  2. Wojcicki uses her nonprofit to acquire 23andMe amid a lawsuit over genetic data privacy.

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • Unknown outlet